Pyroglyphidae

5 trials

Sponsors

National Biopreparations Center (BIOCEN), National Center of Bioproducts (BIOCEN)

Conditions

AsthmaAsthma.Bronchial asthmaBronchial asthma.

Phase 2

Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults

Active, not recruitingRPCEC00000030

National Biopreparations Center (BIOCEN)Bronchial asthma.

Start: 2005-09-07Updated: 2026-03-30

Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics.

Active, not recruitingRPCEC00000032

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2006-05-10Updated: 2026-03-30

Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II

RecruitingRPCEC00000240

National Center of Bioproducts (BIOCEN)Asthma

Start: 2019-02-07Target: 120Updated: 2026-03-30

Phase 3

Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults.

Active, not recruitingRPCEC00000028

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-16Updated: 2026-03-30

Phase 4

Pharmacovigilance-VALERGEN-Asthma

Active, not recruitingRPCEC00000231

National Center of Bioproducts (BIOCEN)Asthma.

Start: 2011-02-01Target: 2108Updated: 2026-03-30